flumazenil has been researched along with Heritable Pulmonary Arterial Hypertension in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tenorio, J | 1 |
Navas, P | 1 |
Barrios, E | 1 |
Fernández, L | 1 |
Nevado, J | 1 |
Quezada, CA | 1 |
López-Meseguer, M | 1 |
Arias, P | 1 |
Mena, R | 1 |
Lobo, JL | 1 |
Alvarez, C | 1 |
Heath, K | 1 |
Escribano-Subías, P | 1 |
Lapunzina, P | 1 |
1 other study available for flumazenil and Heritable Pulmonary Arterial Hypertension
Article | Year |
---|---|
A founder EIF2AK4 mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies.
Topics: Adolescent; Adult; Base Sequence; Familial Primary Pulmonary Hypertension; Female; Founder Effect; G | 2015 |